RU2018102449A3 - - Google Patents

Download PDF

Info

Publication number
RU2018102449A3
RU2018102449A3 RU2018102449A RU2018102449A RU2018102449A3 RU 2018102449 A3 RU2018102449 A3 RU 2018102449A3 RU 2018102449 A RU2018102449 A RU 2018102449A RU 2018102449 A RU2018102449 A RU 2018102449A RU 2018102449 A3 RU2018102449 A3 RU 2018102449A3
Authority
RU
Russia
Application number
RU2018102449A
Other languages
Russian (ru)
Other versions
RU2018102449A (ru
RU2712196C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018102449A publication Critical patent/RU2018102449A/ru
Publication of RU2018102449A3 publication Critical patent/RU2018102449A3/ru
Application granted granted Critical
Publication of RU2712196C2 publication Critical patent/RU2712196C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2018102449A 2015-06-24 2016-06-10 Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии RU2712196C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15173687 2015-06-24
EP15173687.3 2015-06-24
PCT/EP2016/063383 WO2016206999A1 (en) 2015-06-24 2016-06-10 Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy

Publications (3)

Publication Number Publication Date
RU2018102449A RU2018102449A (ru) 2019-07-24
RU2018102449A3 true RU2018102449A3 (enExample) 2019-08-20
RU2712196C2 RU2712196C2 (ru) 2020-01-24

Family

ID=53483747

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018102449A RU2712196C2 (ru) 2015-06-24 2016-06-10 Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии

Country Status (10)

Country Link
US (1) US10407429B2 (enExample)
EP (1) EP3313842B1 (enExample)
JP (1) JP6689299B2 (enExample)
CN (1) CN107949563B (enExample)
AU (1) AU2016284638B2 (enExample)
BR (1) BR112017026061B1 (enExample)
CA (1) CA2989722C (enExample)
RU (1) RU2712196C2 (enExample)
WO (1) WO2016206999A1 (enExample)
ZA (1) ZA201800485B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017147526A1 (en) 2016-02-26 2017-08-31 The Board Of Trustees Of The Leland Stanford Junior University Pi-kinase inhibitors with anti-infective activity
ES2880327T3 (es) 2017-04-05 2021-11-24 Curovir Ab Compuestos heteroaromáticos útiles en terapia
WO2019141694A1 (en) 2018-01-17 2019-07-25 Glaxosmithkline Intellectual Property Development Limited Pi4kiiibeta inhibitors
CN118084937A (zh) 2018-08-21 2024-05-28 杏林制药株式会社 双环杂芳族环衍生物
BR112021006388A2 (pt) 2018-10-10 2021-07-06 Curovir Ab composto, composição farmacêutica, uso de um composto, e, método para tratamento de uma infecção viral em um mamífero
WO2020074160A1 (en) 2018-10-10 2020-04-16 Curovir Ab Condensed pyrimidine or pyridazine derivatives as antiviral agents
US20220062243A1 (en) * 2019-01-11 2022-03-03 Jeffrey S. Glenn P14-Kinase Inhibitors with Anti-Cancer Activity
MX2021011501A (es) 2019-03-21 2022-01-18 Univ Leland Stanford Junior Inhibidores de pi4-cinasa y métodos para usar los mismos.
EP4028131B1 (en) 2019-08-20 2023-11-22 Curovir Ab Heteroaromatic compounds useful in therapy
CN113801119B (zh) * 2021-08-30 2022-09-30 新乡医学院 一种吡唑并[1,3,5]三嗪类化合物的合成方法
EP4676485A1 (en) 2023-03-09 2026-01-14 Curovir Ab Compound and formulation for systemic therapy by oral transmucosal administration

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313124B1 (en) * 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6191131B1 (en) * 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
CN1137123C (zh) * 1998-01-28 2004-02-04 杜邦药品公司 吡咯并三嗪和嘧啶化合物
CN1377354A (zh) * 1999-09-30 2002-10-30 纽罗杰有限公司 某些亚烷基二胺一取代的吡唑并[1,5-a]-1,5-嘧啶和吡唑并[1,5-a]-1,3,5-三嗪
GB0716292D0 (en) * 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
FR2943058B1 (fr) 2009-03-11 2011-06-03 Centre Nat Rech Scient Derives de pyrazolo°1,5-a!-1,3,5-triazines, leur preparation et leur application en therapeutique.
US8633198B1 (en) * 2011-09-20 2014-01-21 Nant Holdings Ip, Llc Small molecule inhibitors of influenza A RNA-dependent RNA polymerase
EP2634190A1 (en) * 2012-03-01 2013-09-04 Lead Discovery Center GmbH Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors
EP2634189A1 (en) 2012-03-01 2013-09-04 Lead Discovery Center GmbH Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors
EP2920181B1 (en) * 2012-11-16 2019-01-09 University Health Network Pyrazolopyrimidine compounds

Also Published As

Publication number Publication date
HK1254809A1 (en) 2019-07-26
WO2016206999A1 (en) 2016-12-29
EP3313842B1 (en) 2020-04-15
BR112017026061B1 (pt) 2023-03-28
RU2018102449A (ru) 2019-07-24
CA2989722A1 (en) 2016-12-29
JP6689299B2 (ja) 2020-04-28
CN107949563A (zh) 2018-04-20
US20180298007A1 (en) 2018-10-18
US10407429B2 (en) 2019-09-10
ZA201800485B (en) 2020-05-27
RU2712196C2 (ru) 2020-01-24
BR112017026061A2 (pt) 2018-08-14
NZ738280A (en) 2024-10-25
EP3313842A1 (en) 2018-05-02
AU2016284638A1 (en) 2018-01-18
JP2018522861A (ja) 2018-08-16
CA2989722C (en) 2023-09-19
CN107949563B (zh) 2020-06-05
AU2016284638B2 (en) 2020-01-23

Similar Documents

Publication Publication Date Title
BR112018002757A2 (enExample)
RU2018102449A3 (enExample)
BR112018002934A2 (enExample)
BR0002402B1 (enExample)
BR0009761B1 (enExample)
CN303071871S (enExample)
CN303071271S (enExample)
CN303071151S (enExample)
CN303069963S (enExample)
CN303069595S (enExample)
CN303067519S (enExample)
BR9715389A2 (enExample)
CN303074548S (enExample)
CN303074653S (enExample)
BR0305327B1 (enExample)
BR0008604B1 (enExample)
BR0009942B1 (enExample)
BR0009757B1 (enExample)
BR0009717B1 (enExample)
BR0009649B1 (enExample)
BR0009373B1 (enExample)
BR0009349B1 (enExample)
BR0009182B1 (enExample)
BR0008874B1 (enExample)
BR0009994B1 (enExample)